GENMIN LIMITED

ASX:GENMaterials

3.46B shares on issueASX (delayed) · snapshot 11 Sept 20264.82B fully diluted+39.4% if every option and right converts$0.007price · delayed$24.2Mmarket cap · indicative

Today’s holders own 71.7% of what they think they own, once every option and right converts.

Very high

Dilution risk

Runway under 2 quarters; share count grew 404% in 24 months; options/rights overhang 39% of shares

Absolute levels — not a ranking against other companies.

Cash runway-0.6 quarters of funding

Share-count growth (24m)404.1%

Raise cadence (24m)2 cash raises

Options & rights overhang39.4% of shares

In-the-money supplyno data — no exercise price on record

Pending proposed issuesnone

GENMIN LIMITED's ordinary share count grew 404.1% between August 2024 and May 2026, reaching 3.46B shares. In the past 24 months, the company completed two capital raises totalling A$18.9M, with the latest being a A$17.4M placement in November 2025. Options and rights on issue represent a potential 1.36B new shares, which is 39.4% of the current share count. The nearest expiry for these options is December 2027. As of the June 2026 quarter, GENMIN LIMITED reported negative A$-2.9M in cash, indicating a deficit of 0.6 quarters of funding at its recent spending rate. No proposed securities issues are currently pending.

AI-generated summary of this page's cited filings · updated 11 Sept 2026

Get told when this changes

Set up alerts

Daily email alerts cover risk-level moves, new raises, pending proposed issues and option expiries for the companies you follow.

39.4%

Options & rights overhang

—

In-the-money supply · no stated strikes

Raises · last 12 months

-0.6 qtrs

Cash cover · under 2 quarters

Shares on issue — last 2 years

Ordinary shares on issue

Weekly counts from ASX records. Dots mark cash capital raises. Latest count 3.46B per ASX (delayed) (snapshot 11 Sept 2026).

Cash runway

-0.6 qtrs

Less than two quarters of funding at the recent spend rate — near-term funding pressure.

$-3.0M cash after burn from the quarter ended 30 June 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds. Filed with the quarterly report: $1.3M cash at quarter end (item 4.6), 0.3 qtrs of funding on the company’s own estimate. Our figure above carries the filed quarter-end balance forward at the reported spend rate and adds announced raise proceeds.

Free account

11 quarters on record — Cash runway history

Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 30 June 2026.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

Date	Form	Security	On issue, per this filing	Source
6 May 2026	2A · quoted issue	GEN : ORDINARY FULLY PAID	3.46B	Appendix 2A
7 Apr 2026	3H · cancellation	GEN : ORDINARY FULLY PAID	3.46B	Appendix 3H
10 Mar 2026	3H · cancellation	GEN : ORDINARY FULLY PAID	3.46B	Appendix 3H
18 Dec 2025	2A · quoted issue	GEN : ORDINARY FULLY PAID	3.44B	Appendix 2A
9 Dec 2025	3G · unquoted	ORDINARY FULLY PAID	1.02B	Appendix 3G

Free account

27 filings on record — Full issuance history

Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Capital raises

2 cash raises in the last 24 months · 1 in the last 12 months

every 11.4 monthsaverage gap between raises

10 monthssince the most recent

29 Nov 2024 – 12 Nov 2025first to most recent in this window

$17.4M

Placement

12 Nov 2025

Free account

2 raises on record — Full raise history

Issue price, shares issued, brokers and stated purpose for every raise on record.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

Free account

1 dated event on record — Forward supply calendar

Option expiries and proposed issues on one forward timeline, with the securities each could add.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.

No estimate — the filings already exceed 15% of the share count we can measure, which means securities were added to the base during the year that we cannot see.

Free account

Placement capacity — LR 7.1 / 7.1A

The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

39.4%

Options & rights overhang · of current shares

—

In-the-money supply · no stated strikes

1.36B

Potential new shares

Dec 2027

Nearest expiry

What this supply is, and what converts it

Price-triggered1.36B · 39.3% of shares
Options and warrants — they convert when the share price clears their exercise price.
No exercise price is on record for any of it, so none of it can be called in or out of the money.
Condition-triggered4.9M · 0.1% of shares
Performance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.

Exercise price on record: 0 priced, 1.36B where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.

Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.

What a price move would switch on

No option supply on record carries an exercise price to pay, so no share price switches any of it on. All 1.36B of it converts on something else — a hurdle that may never be met, or terms the filing does not price.

Code	Security	Type	Exercise price	Expiry	On issue	Source
GENO	Options	Price-triggered	—	18 Dec 2027	1.36B	Filing
GENAE	Performance rights	Condition-triggered	—	—	4.9M	Filing Meeting

“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.

A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.

Free account

2 option lines on record — In-the-money value & price ladder

What each line is worth in the money today, the price ladder to the next tranche that converts, and the filing description behind every code.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Director dealings

Date	Director	Type	Shares	Options	Other	Value	Source
29 May 2026	John Hodder	Buy on-market	11.8M	260.5M	—	$83k	3Y notice
7 Apr 2026	John Hodder	Sell	537.9M	265.5M	—	—	3Y notice
7 Apr 2026	Salvatore Pietro Amico	Sell	886k	295k	—	—	3Y notice